Legislative headlines, not company announcements, have been steering attention toward Novavax (NVAX). Bipartisan lawmakers ...

Earlier this month, Novavax participated in investor-focused healthcare conferences hosted by Citigroup and Cantor Fitzgerald ...

CEO John Jacobs highlighted the shift in Novavax's corporate strategy over the past year, transitioning from a primary focus on commercializing its COVID-19 vaccine to optimizing existing partnerships ...

Novavax’s alliance with Sanofi came at an opportune time for the beleaguered vaccine developer. Its protein-based Covid-19 vaccine never reached the revenue highs achieved by the messenger RNA ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Novavax, Inc.'s Q4 2024 earnings — released yesterday — show a significant revenue decline and continued losses, despite cost-cutting measures and the deal with Sanofi, worth up to $1.2bn. The company ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up who ...